Stamatakou Eleanna, Wróbel Lidia, Hill Sandra Malmgren, Puri Claudia, Son Sung Min, Fujimaki Motoki, Zhu Ye, Siddiqi Farah, Fernandez-Estevez Marian, Manni Marco M, Park So Jung, Villeneuve Julien, Rubinsztein David Chaim
1Department of Medical Genetics, Cambridge Institute for Medical Research, Cambridge, CB2 0XY UK.
UK Dementia Research Institute, The Keith Peters Building, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0XY UK.
Cell Discov. 2020 May 5;6:24. doi: 10.1038/s41421-020-0158-y. eCollection 2020.
The lysosomal degradation pathway of macroautophagy (herein referred to as autophagy) plays a crucial role in cellular physiology by regulating the removal of unwanted cargoes such as protein aggregates and damaged organelles. Over the last five decades, significant progress has been made in understanding the molecular mechanisms that regulate autophagy and its roles in human physiology and diseases. These advances, together with discoveries in human genetics linking autophagy-related gene mutations to specific diseases, provide a better understanding of the mechanisms by which autophagy-dependent pathways can be potentially targeted for treating human diseases. Here, we review mutations that have been identified in genes involved in autophagy and their associations with neurodegenerative diseases.
巨自噬(以下简称自噬)的溶酶体降解途径通过调节清除诸如蛋白质聚集体和受损细胞器等不需要的物质,在细胞生理学中发挥着关键作用。在过去的五十年里,在理解调节自噬的分子机制及其在人类生理学和疾病中的作用方面取得了重大进展。这些进展,连同人类遗传学中关于自噬相关基因突变与特定疾病联系的发现,使人们更好地理解了自噬依赖途径可能成为治疗人类疾病靶点的机制。在此,我们综述了自噬相关基因中已鉴定出的突变及其与神经退行性疾病的关联。